Vident Investment Advisory’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,994	Closed	-$695K	–	1280
2022 Q1	$695K	Buy	2,994 +492	+20%	+$157K	0.02%	822
2021 Q4	$986K	Sell	2,502 -1,552	-38%	-$653K	0.03%	712
2021 Q3	$1.81M	Sell	4,054 -290	-7%	-$104K	0.05%	472
2021 Q2	$1.69M	Buy	4,344 +1,634	+60%	+$583K	0.05%	474
2021 Q1	$973K	Sell	2,710 -14	-0.5%	-$6.19K	0.03%	616
2020 Q4	$1.34M	Buy	+2,724	New	+$1.26M	0.05%	449
2020 Q2	–	Sell	-3,662	Closed	-$779K	–	841
2020 Q1	$779K	Sell	3,662 -229	-6%	-$72.7K	0.05%	464
2019 Q4	$1.6M	Buy	3,891 +1,328	+52%	+$458K	0.1%	317
2019 Q3	$905K	Sell	2,563 -73	-3%	-$27.2K	0.08%	188
2019 Q2	$1.32M	Buy	2,636 +1,186	+82%	+$837K	0.11%	134
2019 Q1	$1.44M	Sell	1,450 -38	-3%	-$35.3K	0.08%	355
2018 Q4	$1.29M	Sell	1,488 -572	-28%	-$531K	0.07%	364
2018 Q3	$2.13M	Sell	2,060 -137	-6%	-$134K	0.08%	312
2018 Q2	$2.02M	Sell	2,197 -2,515	-53%	-$2.7M	0.08%	324
2018 Q1	$4.56M	Buy	4,712 +1,280	+37%	+$1.17M	0.19%	77
2017 Q4	$1.55M	Sell	3,432 -305	-8%	-$113K	0.07%	310
2017 Q3	$1.55M	Buy	3,737 +113	+3%	+$42.6K	0.08%	309
2017 Q2	$1.27M	Buy	3,624 +1,397	+63%	+$538K	0.11%	298
2017 Q1	$1.14M	Buy	2,227 +371	+20%	+$154K	0.11%	295
2016 Q4	$659K	Buy	1,856 +547	+42%	+$232K	0.08%	321
2016 Q3	$700K	Sell	1,309 -6	-0.5%	-$3.26K	0.09%	316
2016 Q2	$740K	Sell	1,315 -372	-22%	-$179K	0.1%	303
2016 Q1	$802	Buy	1,687 +787	+87%	+$354K	0.05%	358
2015 Q4	$594K	Buy	+900	New	+$681K	0.08%	351

Other funds holding ATRA